| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Status Epilepticus | 35 | 2023 | 150 | 6.380 |
Why?
|
| Electroencephalography | 61 | 2024 | 972 | 5.490 |
Why?
|
| Anticonvulsants | 41 | 2024 | 445 | 4.550 |
Why?
|
| Drug Resistant Epilepsy | 14 | 2024 | 213 | 3.520 |
Why?
|
| Neurology | 9 | 2024 | 119 | 3.470 |
Why?
|
| Epilepsy | 31 | 2024 | 946 | 3.340 |
Why?
|
| Seizures | 34 | 2024 | 1032 | 3.080 |
Why?
|
| Critical Care | 14 | 2024 | 810 | 2.720 |
Why?
|
| Spasms, Infantile | 6 | 2023 | 163 | 1.980 |
Why?
|
| Neurophysiological Monitoring | 2 | 2024 | 36 | 1.510 |
Why?
|
| Intensive Care Units, Pediatric | 6 | 2024 | 477 | 1.450 |
Why?
|
| Child | 106 | 2024 | 30492 | 1.320 |
Why?
|
| Laser Therapy | 3 | 2023 | 465 | 1.260 |
Why?
|
| Pediatrics | 6 | 2024 | 1184 | 1.240 |
Why?
|
| Monitoring, Physiologic | 14 | 2022 | 536 | 1.200 |
Why?
|
| Tuberous Sclerosis | 3 | 2023 | 144 | 1.110 |
Why?
|
| Brain Diseases | 9 | 2023 | 414 | 1.090 |
Why?
|
| Brain Waves | 4 | 2018 | 50 | 0.910 |
Why?
|
| Stereotaxic Techniques | 4 | 2020 | 184 | 0.900 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2009 | 78 | 0.890 |
Why?
|
| Child, Preschool | 65 | 2023 | 16999 | 0.880 |
Why?
|
| Hemispherectomy | 1 | 2023 | 27 | 0.860 |
Why?
|
| Phenytoin | 4 | 2020 | 83 | 0.860 |
Why?
|
| Clinical Protocols | 4 | 2021 | 485 | 0.820 |
Why?
|
| Landau-Kleffner Syndrome | 4 | 2014 | 7 | 0.810 |
Why?
|
| Electric Stimulation Therapy | 4 | 2024 | 132 | 0.780 |
Why?
|
| Critical Illness | 5 | 2023 | 741 | 0.770 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2013 | 209 | 0.750 |
Why?
|
| Epilepsy, Generalized | 6 | 2023 | 69 | 0.740 |
Why?
|
| Brain | 13 | 2021 | 4252 | 0.710 |
Why?
|
| Benzodiazepines | 7 | 2023 | 174 | 0.710 |
Why?
|
| Infant | 44 | 2023 | 13931 | 0.680 |
Why?
|
| Evidence-Based Medicine | 4 | 2021 | 1059 | 0.670 |
Why?
|
| Humans | 145 | 2024 | 271884 | 0.640 |
Why?
|
| Hypnotics and Sedatives | 3 | 2015 | 220 | 0.630 |
Why?
|
| Sodium Channel Blockers | 1 | 2018 | 37 | 0.630 |
Why?
|
| Coma | 1 | 2018 | 67 | 0.620 |
Why?
|
| Brain Ischemia | 2 | 2018 | 316 | 0.590 |
Why?
|
| Heart Diseases | 1 | 2024 | 739 | 0.590 |
Why?
|
| Encephalitis | 4 | 2023 | 153 | 0.580 |
Why?
|
| Propofol | 4 | 2013 | 80 | 0.560 |
Why?
|
| Seizures, Febrile | 3 | 2021 | 20 | 0.560 |
Why?
|
| Cerebral Cortex | 12 | 2012 | 636 | 0.520 |
Why?
|
| Epilepsies, Partial | 7 | 2018 | 110 | 0.520 |
Why?
|
| Adolescent | 55 | 2024 | 32663 | 0.510 |
Why?
|
| Maple Syrup Urine Disease | 2 | 2012 | 16 | 0.500 |
Why?
|
| Brain Injuries | 1 | 2021 | 801 | 0.490 |
Why?
|
| Hippocampus | 1 | 2020 | 976 | 0.480 |
Why?
|
| Agnosia | 1 | 2014 | 5 | 0.470 |
Why?
|
| Hypothalamic Diseases | 3 | 2022 | 42 | 0.470 |
Why?
|
| Time-to-Treatment | 4 | 2021 | 312 | 0.460 |
Why?
|
| Nervous System Diseases | 4 | 2024 | 522 | 0.460 |
Why?
|
| Hamartoma | 3 | 2022 | 89 | 0.460 |
Why?
|
| Intensive Care Units | 2 | 2016 | 743 | 0.460 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 302 | 0.450 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 3 | 2023 | 104 | 0.430 |
Why?
|
| Retrospective Studies | 33 | 2024 | 39780 | 0.420 |
Why?
|
| Spasm | 2 | 2023 | 59 | 0.420 |
Why?
|
| Sleep | 5 | 2014 | 443 | 0.420 |
Why?
|
| Expert Testimony | 1 | 2013 | 85 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2023 | 7929 | 0.410 |
Why?
|
| Biological Clocks | 1 | 2012 | 39 | 0.400 |
Why?
|
| Diazepam | 4 | 2023 | 45 | 0.390 |
Why?
|
| Male | 71 | 2024 | 128957 | 0.370 |
Why?
|
| Midazolam | 4 | 2021 | 72 | 0.370 |
Why?
|
| Treatment Outcome | 24 | 2024 | 33863 | 0.370 |
Why?
|
| Epileptic Syndromes | 2 | 2021 | 28 | 0.360 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 286 | 0.360 |
Why?
|
| Infant, Newborn | 17 | 2022 | 8602 | 0.360 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2022 | 180 | 0.360 |
Why?
|
| Epilepsy, Frontal Lobe | 3 | 2007 | 11 | 0.350 |
Why?
|
| Carbamazepine | 2 | 2007 | 56 | 0.340 |
Why?
|
| Brain Neoplasms | 2 | 2024 | 4993 | 0.340 |
Why?
|
| Nervous System Malformations | 2 | 2009 | 135 | 0.330 |
Why?
|
| Pentobarbital | 3 | 2013 | 28 | 0.320 |
Why?
|
| Valproic Acid | 3 | 2013 | 276 | 0.320 |
Why?
|
| Societies, Medical | 3 | 2018 | 1349 | 0.320 |
Why?
|
| Nocturnal Paroxysmal Dystonia | 1 | 2007 | 1 | 0.310 |
Why?
|
| Female | 69 | 2024 | 149143 | 0.300 |
Why?
|
| Functional Laterality | 4 | 2020 | 285 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 2429 | 0.290 |
Why?
|
| Specialization | 1 | 2008 | 129 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2020 | 5104 | 0.270 |
Why?
|
| Medicine | 1 | 2008 | 140 | 0.270 |
Why?
|
| Emergency Treatment | 2 | 2018 | 105 | 0.270 |
Why?
|
| Fructose | 3 | 2002 | 70 | 0.270 |
Why?
|
| Neuroimaging | 2 | 2024 | 404 | 0.270 |
Why?
|
| Acute Disease | 6 | 2018 | 2514 | 0.260 |
Why?
|
| Vigabatrin | 2 | 2023 | 19 | 0.260 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2006 | 207 | 0.250 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 699 | 0.250 |
Why?
|
| Vagus Nerve | 2 | 2003 | 70 | 0.250 |
Why?
|
| Thalamus | 3 | 2012 | 123 | 0.240 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 1999 | 286 | 0.240 |
Why?
|
| Consensus | 2 | 2024 | 1116 | 0.240 |
Why?
|
| Apnea | 1 | 2023 | 36 | 0.230 |
Why?
|
| Developmental Disabilities | 6 | 2016 | 689 | 0.220 |
Why?
|
| Autistic Disorder | 3 | 2022 | 350 | 0.220 |
Why?
|
| Anesthetics, Intravenous | 2 | 2001 | 71 | 0.220 |
Why?
|
| Clinical Competence | 1 | 2011 | 1327 | 0.210 |
Why?
|
| Hallucinations | 1 | 2003 | 34 | 0.210 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2001 | 110 | 0.210 |
Why?
|
| Neurophysiology | 2 | 2013 | 22 | 0.210 |
Why?
|
| Phenobarbital | 3 | 2020 | 56 | 0.210 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 1242 | 0.200 |
Why?
|
| Piracetam | 2 | 2013 | 8 | 0.200 |
Why?
|
| Temporal Lobe | 4 | 2004 | 190 | 0.200 |
Why?
|
| Psychosurgery | 1 | 2001 | 27 | 0.190 |
Why?
|
| Electrodes | 2 | 2020 | 132 | 0.190 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1999 | 169 | 0.190 |
Why?
|
| Language Development Disorders | 1 | 2022 | 166 | 0.190 |
Why?
|
| Epilepsies, Myoclonic | 2 | 1998 | 27 | 0.190 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 1259 | 0.190 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2021 | 55 | 0.180 |
Why?
|
| Acidosis | 2 | 2002 | 116 | 0.180 |
Why?
|
| Hypothermia, Induced | 3 | 2001 | 177 | 0.180 |
Why?
|
| Epilepsy, Absence | 3 | 1998 | 34 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 609 | 0.180 |
Why?
|
| Electric Stimulation | 4 | 2011 | 492 | 0.180 |
Why?
|
| Stroke | 3 | 2021 | 1094 | 0.170 |
Why?
|
| Drug Interactions | 2 | 2018 | 584 | 0.170 |
Why?
|
| Photoperiod | 1 | 2019 | 25 | 0.170 |
Why?
|
| Positron-Emission Tomography | 2 | 2008 | 2198 | 0.160 |
Why?
|
| Hospitalization | 5 | 2022 | 2202 | 0.160 |
Why?
|
| Brain Mapping | 4 | 2018 | 640 | 0.160 |
Why?
|
| Neocortex | 2 | 2004 | 97 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 1999 | 118 | 0.160 |
Why?
|
| Drug Evaluation | 1 | 2018 | 435 | 0.150 |
Why?
|
| Disease Management | 1 | 2024 | 1111 | 0.150 |
Why?
|
| Craniotomy | 1 | 2000 | 304 | 0.150 |
Why?
|
| Neurosurgical Procedures | 3 | 2011 | 634 | 0.150 |
Why?
|
| 4-Aminobutyrate Transaminase | 1 | 2017 | 8 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2018 | 2139 | 0.140 |
Why?
|
| Cyclosporine | 1 | 1998 | 296 | 0.140 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 1441 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2021 | 632 | 0.140 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2016 | 31 | 0.140 |
Why?
|
| Cerebral Infarction | 2 | 1995 | 72 | 0.130 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2017 | 102 | 0.130 |
Why?
|
| Frontal Lobe | 3 | 2015 | 177 | 0.130 |
Why?
|
| Young Adult | 12 | 2024 | 22108 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2020 | 649 | 0.130 |
Why?
|
| Time Factors | 8 | 2021 | 13130 | 0.130 |
Why?
|
| Inpatients | 1 | 2021 | 695 | 0.130 |
Why?
|
| Mydriasis | 1 | 1995 | 7 | 0.130 |
Why?
|
| Neuromyelitis Optica | 1 | 1996 | 30 | 0.130 |
Why?
|
| Organ Transplantation | 1 | 1998 | 203 | 0.130 |
Why?
|
| Life Support Care | 1 | 2015 | 52 | 0.130 |
Why?
|
| Diagnosis, Differential | 11 | 2017 | 4891 | 0.130 |
Why?
|
| Quality of Life | 4 | 2024 | 4749 | 0.130 |
Why?
|
| Amobarbital | 1 | 2015 | 7 | 0.130 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 183 | 0.120 |
Why?
|
| Age Factors | 8 | 2020 | 5520 | 0.120 |
Why?
|
| Recurrence | 2 | 2020 | 4886 | 0.120 |
Why?
|
| Intellectual Disability | 3 | 2016 | 1055 | 0.120 |
Why?
|
| Follow-Up Studies | 12 | 2021 | 15267 | 0.120 |
Why?
|
| Gestational Age | 1 | 2018 | 1153 | 0.120 |
Why?
|
| Prospective Studies | 10 | 2021 | 13400 | 0.120 |
Why?
|
| Port-Wine Stain | 1 | 2014 | 5 | 0.120 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2014 | 8 | 0.120 |
Why?
|
| Brain Edema | 2 | 2010 | 96 | 0.110 |
Why?
|
| Carbon Dioxide | 2 | 2001 | 331 | 0.110 |
Why?
|
| Cytokines | 1 | 2023 | 2840 | 0.110 |
Why?
|
| Epilepsy, Tonic-Clonic | 4 | 1999 | 16 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 460 | 0.110 |
Why?
|
| Lorazepam | 1 | 2013 | 40 | 0.110 |
Why?
|
| Drug Administration Schedule | 5 | 2018 | 3539 | 0.110 |
Why?
|
| Cyclohexanecarboxylic Acids | 3 | 1998 | 43 | 0.110 |
Why?
|
| Drug Therapy, Combination | 5 | 2001 | 2366 | 0.110 |
Why?
|
| Drug Resistance | 2 | 2005 | 615 | 0.110 |
Why?
|
| Amines | 3 | 1998 | 86 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 460 | 0.100 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2012 | 13 | 0.100 |
Why?
|
| Delta Rhythm | 1 | 1992 | 5 | 0.100 |
Why?
|
| Hospital Mortality | 2 | 2021 | 1317 | 0.100 |
Why?
|
| Munc18 Proteins | 1 | 2012 | 39 | 0.100 |
Why?
|
| Acetates | 3 | 1998 | 122 | 0.100 |
Why?
|
| Adult | 17 | 2023 | 81857 | 0.100 |
Why?
|
| Cerebrum | 1 | 2012 | 41 | 0.100 |
Why?
|
| Disability Evaluation | 1 | 2013 | 242 | 0.100 |
Why?
|
| Hospitals, Pediatric | 3 | 2022 | 790 | 0.100 |
Why?
|
| Administration, Intravenous | 1 | 2013 | 251 | 0.100 |
Why?
|
| Laughter | 1 | 2011 | 10 | 0.100 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2013 | 145 | 0.100 |
Why?
|
| Mental Disorders | 1 | 1999 | 884 | 0.100 |
Why?
|
| Malformations of Cortical Development | 1 | 2012 | 58 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 6210 | 0.100 |
Why?
|
| Gain of Function Mutation | 2 | 2023 | 134 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 1992 | 160 | 0.100 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 527 | 0.100 |
Why?
|
| Hemiplegia | 3 | 2023 | 48 | 0.100 |
Why?
|
| Weights and Measures | 1 | 2010 | 6 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2012 | 296 | 0.090 |
Why?
|
| Brain Stem | 2 | 1990 | 185 | 0.090 |
Why?
|
| Trisomy | 1 | 2012 | 240 | 0.090 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 60 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 268 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 1992 | 189 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1598 | 0.090 |
Why?
|
| Plasmapheresis | 1 | 1990 | 51 | 0.090 |
Why?
|
| Dexamethasone | 1 | 1996 | 1497 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2023 | 600 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 355 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2013 | 420 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 1102 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 1707 | 0.090 |
Why?
|
| Risk Factors | 3 | 2024 | 18045 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 566 | 0.090 |
Why?
|
| Hepatic Encephalopathy | 1 | 1990 | 89 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 144 | 0.090 |
Why?
|
| Neurogenesis | 1 | 2012 | 240 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2010 | 61 | 0.090 |
Why?
|
| Critical Pathways | 1 | 2011 | 160 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 371 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 265 | 0.080 |
Why?
|
| Algorithms | 2 | 2011 | 3923 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2021 | 9491 | 0.080 |
Why?
|
| Hypothalamus | 1 | 2011 | 276 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2014 | 473 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 497 | 0.080 |
Why?
|
| Age Distribution | 1 | 2011 | 730 | 0.080 |
Why?
|
| Electrodes, Implanted | 4 | 2018 | 186 | 0.080 |
Why?
|
| Kainic Acid | 1 | 2008 | 41 | 0.080 |
Why?
|
| United States | 6 | 2023 | 16050 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2010 | 2903 | 0.080 |
Why?
|
| Rats, Long-Evans | 1 | 2008 | 111 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 911 | 0.080 |
Why?
|
| Occupations | 1 | 2008 | 54 | 0.080 |
Why?
|
| Cerebral Aqueduct | 1 | 1988 | 10 | 0.080 |
Why?
|
| Statistics, Nonparametric | 3 | 2018 | 995 | 0.080 |
Why?
|
| Brain Death | 1 | 1988 | 59 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2008 | 338 | 0.070 |
Why?
|
| Canada | 2 | 2023 | 441 | 0.070 |
Why?
|
| Phenotype | 4 | 2023 | 6515 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2012 | 1436 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2012 | 1487 | 0.070 |
Why?
|
| Toxicology | 1 | 2006 | 13 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 751 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 1990 | 350 | 0.070 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2006 | 24 | 0.070 |
Why?
|
| Infant, Premature | 1 | 1992 | 828 | 0.070 |
Why?
|
| Postoperative Complications | 5 | 1997 | 5690 | 0.070 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2010 | 372 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2006 | 62 | 0.070 |
Why?
|
| Career Choice | 1 | 2008 | 209 | 0.070 |
Why?
|
| Neurofibromatosis 1 | 1 | 1988 | 151 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 5928 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 115 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 1015 | 0.070 |
Why?
|
| Thiopental | 1 | 2005 | 9 | 0.070 |
Why?
|
| Evoked Potentials | 3 | 1995 | 229 | 0.060 |
Why?
|
| Evoked Potentials, Somatosensory | 3 | 1996 | 67 | 0.060 |
Why?
|
| Prognosis | 6 | 2011 | 22537 | 0.060 |
Why?
|
| Hypoxia | 1 | 1988 | 477 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2005 | 106 | 0.060 |
Why?
|
| Choristoma | 1 | 2005 | 87 | 0.060 |
Why?
|
| Fentanyl | 2 | 2011 | 153 | 0.060 |
Why?
|
| Motor Skills Disorders | 1 | 2004 | 18 | 0.060 |
Why?
|
| Nervous System | 1 | 2005 | 183 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 2085 | 0.060 |
Why?
|
| Bicarbonates | 2 | 2002 | 114 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 281 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 171 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 2024 | 27 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2008 | 2337 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 2006 | 210 | 0.060 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 1996 | 32 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2003 | 7790 | 0.060 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2003 | 19 | 0.060 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2023 | 41 | 0.060 |
Why?
|
| Paresthesia | 1 | 2003 | 33 | 0.060 |
Why?
|
| Pharyngeal Diseases | 1 | 2003 | 51 | 0.050 |
Why?
|
| 4-Aminopyridine | 1 | 2023 | 43 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2004 | 149 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 138 | 0.050 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2023 | 42 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2018 | 1620 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 1994 | 1781 | 0.050 |
Why?
|
| Ketosis | 1 | 2002 | 16 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2023 | 112 | 0.050 |
Why?
|
| Pharynx | 1 | 2003 | 150 | 0.050 |
Why?
|
| Amitriptyline | 1 | 2022 | 37 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2010 | 596 | 0.050 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2022 | 35 | 0.050 |
Why?
|
| Intraoperative Care | 2 | 2001 | 274 | 0.050 |
Why?
|
| Device Approval | 1 | 2001 | 18 | 0.050 |
Why?
|
| Neurologic Examination | 4 | 2001 | 267 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2006 | 629 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2023 | 6236 | 0.050 |
Why?
|
| Craniocerebral Trauma | 1 | 2003 | 155 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2001 | 85 | 0.050 |
Why?
|
| Infectious Encephalitis | 1 | 2020 | 4 | 0.050 |
Why?
|
| Dominance, Cerebral | 3 | 1997 | 79 | 0.050 |
Why?
|
| Wakefulness | 2 | 2012 | 157 | 0.050 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2001 | 27 | 0.050 |
Why?
|
| Age of Onset | 2 | 2004 | 852 | 0.050 |
Why?
|
| Diet, Ketogenic | 1 | 2021 | 24 | 0.050 |
Why?
|
| Incidence | 1 | 2011 | 5861 | 0.050 |
Why?
|
| Cannabidiol | 1 | 2021 | 43 | 0.040 |
Why?
|
| Immune System Diseases | 1 | 2021 | 65 | 0.040 |
Why?
|
| Atrophy | 1 | 2001 | 279 | 0.040 |
Why?
|
| Syndrome | 1 | 2023 | 1405 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2000 | 259 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2001 | 296 | 0.040 |
Why?
|
| Rats | 1 | 2008 | 6638 | 0.040 |
Why?
|
| Organotechnetium Compounds | 2 | 1996 | 48 | 0.040 |
Why?
|
| Deep Brain Stimulation | 1 | 2024 | 396 | 0.040 |
Why?
|
| Telemetry | 2 | 1997 | 41 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 1177 | 0.040 |
Why?
|
| Child Development | 1 | 2001 | 267 | 0.040 |
Why?
|
| Reticular Formation | 1 | 1998 | 4 | 0.040 |
Why?
|
| Excitatory Amino Acids | 1 | 1998 | 11 | 0.040 |
Why?
|
| Psychotropic Drugs | 1 | 1999 | 139 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2018 | 241 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 516 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1694 | 0.040 |
Why?
|
| Receptors, GABA-B | 1 | 1998 | 32 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 1998 | 83 | 0.040 |
Why?
|
| Triazines | 1 | 1998 | 123 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 66 | 0.040 |
Why?
|
| Flumazenil | 1 | 2017 | 8 | 0.040 |
Why?
|
| Mutation | 3 | 2023 | 15924 | 0.040 |
Why?
|
| GABA Modulators | 1 | 2017 | 16 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 330 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2007 | 6883 | 0.040 |
Why?
|
| Pyramidal Cells | 1 | 1998 | 171 | 0.030 |
Why?
|
| Models, Neurological | 1 | 1998 | 241 | 0.030 |
Why?
|
| Fixation, Ocular | 1 | 1996 | 19 | 0.030 |
Why?
|
| Memory | 1 | 2000 | 443 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1997 | 306 | 0.030 |
Why?
|
| Motor Activity | 1 | 2000 | 718 | 0.030 |
Why?
|
| Biopsy | 1 | 2003 | 3544 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1997 | 394 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1995 | 145 | 0.030 |
Why?
|
| Cysteine | 1 | 1996 | 214 | 0.030 |
Why?
|
| Child Behavior Disorders | 1 | 1996 | 76 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 7471 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2001 | 1552 | 0.030 |
Why?
|
| Cerebral Decortication | 1 | 1994 | 1 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 2206 | 0.030 |
Why?
|
| Somatoform Disorders | 1 | 1995 | 60 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 3853 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2015 | 176 | 0.030 |
Why?
|
| Psychophysiologic Disorders | 1 | 1995 | 27 | 0.030 |
Why?
|
| Animals | 3 | 2008 | 62807 | 0.030 |
Why?
|
| Polysomnography | 2 | 2012 | 178 | 0.030 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1995 | 107 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 2287 | 0.030 |
Why?
|
| Cognition | 1 | 2000 | 982 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2015 | 249 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2001 | 4399 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 4352 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 1278 | 0.030 |
Why?
|
| Video Recording | 1 | 1995 | 280 | 0.030 |
Why?
|
| Endoglin | 1 | 2012 | 41 | 0.030 |
Why?
|
| Language | 1 | 2015 | 327 | 0.030 |
Why?
|
| Mammillary Bodies | 1 | 2011 | 3 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 566 | 0.020 |
Why?
|
| Child Behavior | 3 | 2001 | 249 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 5118 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2011 | 8 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 174 | 0.020 |
Why?
|
| Intelligence | 1 | 2012 | 134 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 6909 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 1992 | 84 | 0.020 |
Why?
|
| Dehydration | 1 | 1991 | 91 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2011 | 65 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1995 | 1175 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 303 | 0.020 |
Why?
|
| Exome | 1 | 2016 | 1252 | 0.020 |
Why?
|
| Quadriplegia | 1 | 1990 | 41 | 0.020 |
Why?
|
| Genotype | 1 | 2018 | 4265 | 0.020 |
Why?
|
| Drug Resistance, Multiple | 1 | 2011 | 221 | 0.020 |
Why?
|
| Leigh Disease | 1 | 1990 | 33 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 692 | 0.020 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1990 | 53 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1995 | 1772 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2011 | 221 | 0.020 |
Why?
|
| Asparaginase | 1 | 2010 | 186 | 0.020 |
Why?
|
| Spine | 1 | 2011 | 311 | 0.020 |
Why?
|
| Safety | 1 | 2011 | 465 | 0.020 |
Why?
|
| Primidone | 1 | 1988 | 9 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1997 | 1163 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2001 | 622 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 2053 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 835 | 0.020 |
Why?
|
| Premature Birth | 1 | 2012 | 405 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 16610 | 0.020 |
Why?
|
| Neurons | 1 | 1998 | 2461 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2317 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1990 | 724 | 0.020 |
Why?
|
| Methotrexate | 1 | 2010 | 1032 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 642 | 0.020 |
Why?
|
| Research Design | 1 | 2013 | 1580 | 0.020 |
Why?
|
| Vincristine | 1 | 2010 | 1572 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 3512 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 52 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 2005 | 96 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2011 | 699 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 119 | 0.020 |
Why?
|
| Survival Rate | 1 | 1999 | 12533 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2011 | 774 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2011 | 940 | 0.020 |
Why?
|
| Occipital Lobe | 1 | 2004 | 47 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 362 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4998 | 0.010 |
Why?
|
| Auditory Cortex | 1 | 2004 | 40 | 0.010 |
Why?
|
| Cytarabine | 1 | 2010 | 2014 | 0.010 |
Why?
|
| Videotape Recording | 1 | 2003 | 75 | 0.010 |
Why?
|
| Comorbidity | 2 | 2003 | 2439 | 0.010 |
Why?
|
| Organ Size | 1 | 2004 | 727 | 0.010 |
Why?
|
| Urinary Calculi | 1 | 2002 | 31 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 90395 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 1534 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 1140 | 0.010 |
Why?
|
| Body Temperature | 1 | 2001 | 165 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2001 | 137 | 0.010 |
Why?
|
| Transposition of Great Vessels | 1 | 2001 | 131 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2005 | 1047 | 0.010 |
Why?
|
| Tetralogy of Fallot | 1 | 2001 | 158 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 1514 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 12222 | 0.010 |
Why?
|
| Computer Systems | 1 | 1997 | 117 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 5787 | 0.010 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1996 | 14 | 0.010 |
Why?
|
| Suggestion | 1 | 1995 | 5 | 0.010 |
Why?
|
| Television | 1 | 1996 | 75 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1995 | 43 | 0.010 |
Why?
|
| Subdural Space | 1 | 1995 | 8 | 0.010 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1994 | 11 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 1996 | 84 | 0.010 |
Why?
|
| Electric Countershock | 1 | 1995 | 70 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7822 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1994 | 285 | 0.010 |
Why?
|
| Aggression | 1 | 1996 | 253 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1997 | 973 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1999 | 2619 | 0.010 |
Why?
|
| Oximes | 1 | 1994 | 192 | 0.010 |
Why?
|
| Speech | 1 | 1995 | 140 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 1996 | 244 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1996 | 515 | 0.010 |
Why?
|
| Heart Rate | 1 | 1995 | 761 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 9044 | 0.010 |
Why?
|
| Tectum Mesencephali | 1 | 1990 | 3 | 0.010 |
Why?
|
| Putamen | 1 | 1990 | 26 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1990 | 43 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 1990 | 69 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1995 | 1196 | 0.010 |
Why?
|
| Contrast Media | 1 | 1990 | 1510 | 0.000 |
Why?
|